id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-1992-N-0056-0004,FDA,FDA-1992-N-0056,"Notice of Extension re Prescription Drug Marketing Act of 1987, Drug Amendments of 1992; Policies, Requirements, and Administrative Procedures; Reopening of Comment Period",Notice,Notice of Extension,1994-07-25T04:00:00Z,1994,7,1994-07-25T04:00:00Z,1994-08-16T03:59:59Z,2017-08-04T13:26:56Z,,0,0,090000648052bf07
FDA-1992-N-0056-0003,FDA,FDA-1992-N-0056,Envelope re Comment from Pharmaceutical Manufacturers Association,Supporting & Related Material,Transmittals,1994-04-26T04:00:00Z,1994,4,,,2016-03-15T14:29:57Z,,0,0,090000648052be8e
FDA-1992-N-0056-0001,FDA,FDA-1992-N-0056,"Notice of Proposed Rulemaking re Prescription Drug Marketing Act of 1987, Drug Amendments of 1992",Proposed Rule,NPR-Notice of Proposed Rule-Making,1994-04-26T04:00:00Z,1994,4,1994-04-26T04:00:00Z,1994-05-31T03:59:59Z,2017-08-05T19:09:08Z,,0,0,090000648052be86
FDA-1992-N-0056-0002,FDA,FDA-1992-N-0056,"Notice of Proposed Rulemaking re Prescription Drug Marketing Act of 1987, Drug Amds of 1992",Proposed Rule,Notice of Proposed Rulemaking (NPRM),1994-04-26T04:00:00Z,1994,4,1994-04-26T04:00:00Z,1994-05-31T03:59:59Z,2016-03-15T14:00:22Z,,0,0,090000648052be8c